WW International (WW) expands its integrated GLP-1 platform with access to Wegovy pill (NOVOB DC)
Importance
Level 1
- The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers’ leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support.
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#GLOBAL EQUITIES